Back to Search
Start Over
Superiority of the Triple-Acting 5‑HT6R/5-HT3R Antagonist and MAO‑B Reversible Inhibitor PZ-1922 over 5‑HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats.
- Source :
- Journal of Medicinal Chemistry; 11/9/2023, Vol. 66 Issue 21, p14928-14947, 20p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 00222623
- Volume :
- 66
- Issue :
- 21
- Database :
- Supplemental Index
- Journal :
- Journal of Medicinal Chemistry
- Publication Type :
- Academic Journal
- Accession number :
- 173553810
- Full Text :
- https://doi.org/10.1021/acs.jmedchem.3c01482